Get 5% off qualifying animal health products when you spend $3,000-$4,999.
Get 8% off qualifying animal health products when you spend $5,000 or more
Salmonella Typhimurium and Choleraesuis present significant challenges to herd health and productivity. Clinical signs include clinical diarrhea, often lasting three to seven days, which can lead to dehydration and reduced swine performance. Salmonella Typhimurium also poses food safety risks to humans. As the first and only vaccine offering live attenuated strains of both Choleraesuis and Typhimurium, ENTERISOL SALMONELLA T/C allows you to reduce risks of both serovars with direct protection in a single, oral dose.
The first dual-antigen swine Salmonella vaccine.
Early vaccination age – 2 weeks of age.
Convenient oral delivery.
PQA friendly – no needles.
Another innovative oral vaccine from Boehringer Ingelheim Animal Health.
First and only swine vaccine to contain both Salmonella Choleraesuis and Salmonella Typhimurium antigens in one dose.
Approved for use in pigs as young as 2 weeks of age.
Modified-live vaccine provides rapid onset of immunity after administration and induction of crucial cellular immunity toward Salmonella.
Oral delivery of dual antigens through the water supply directly enters the intestinal tract to induce mucosal immunity.
Oral delivery with “blue-nose verification” provides a convenient, easy-to-confirm method that saves labor costs and time.
ENTERISOL SALMONELLA T/C is available in two formulations: lyophilized (freeze-dried) or frozen.
Enterisol® is a registered trademark of Boehringer Ingelheim Animal Health USA, Inc.